|
Volumn 95, Issue 7, 2002, Pages 743-749
|
Attention-deficit/hyperactivity disorder: An update
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
AMFEBUTAMONE;
AMPHETAMINE;
ANTIDEPRESSANT AGENT;
CARBAMAZEPINE;
CATECHOLAMINE;
CENTRAL STIMULANT AGENT;
CLONIDINE;
DESIPRAMINE;
DEXAMPHETAMINE;
GUANFACINE;
HALOPERIDOL;
LITHIUM;
METHYLPHENIDATE;
MODAFINIL;
NEUROLEPTIC AGENT;
PEMOLINE;
RISPERIDONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VALPROIC ACID;
VENLAFAXINE;
ABDOMINAL DISCOMFORT;
AFFECTIVE NEUROSIS;
ANOREXIA;
ANTISOCIAL BEHAVIOR;
ATTENTION DEFICIT DISORDER;
BASAL GANGLION;
CLINICAL FEATURE;
CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DRUG EFFICACY;
DYSLEXIA;
ELECTROENCEPHALOGRAM;
FRONTAL CORTEX;
GENETIC SUSCEPTIBILITY;
GLUCOSE METABOLISM;
GROWTH RETARDATION;
HEADACHE;
HUMAN;
IMPULSIVENESS;
INSOMNIA;
IRRITABILITY;
LIVER TOXICITY;
NEUROTRANSMISSION;
POSITRON EMISSION TOMOGRAPHY;
PROGNOSIS;
PSYCHIATRIC DIAGNOSIS;
RATING SCALE;
REVIEW;
SIDE EFFECT;
SUBSTANCE ABUSE;
TIC;
TREATMENT OUTCOME;
VALIDATION PROCESS;
|
EID: 0036062464
PISSN: 00384348
EISSN: None
Source Type: Journal
DOI: 10.1097/00007611-200295070-00016 Document Type: Review |
Times cited : (18)
|
References (44)
|